Nearly 3x Revenue Growth and Positive Corporate EBITDA in FY26
- 35,000+ Patients Treated Across Nine States as Dialysis Network Expands to 60+ Centres
- Series B Funding to Drive Global Expansion, AI-Native Care Delivery and 100+ Centre Target by FY27
Gurgaon, 19th November 2026: For people living with chronic kidney disease, dialysis is a long-term commitment that requires consistent access to specialised care. VitusCare, a dialysis care provider focused on expanding access to quality dialysis services across underserved markets, has secured US$3 million (₹XX crore) in a Series B funding participated in by Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors 1Crowd and 3i Partners, and several angel investors.
The funding comes as VitusCare claims strong business growth. Since its previous funding round in late 2024, led by Tomorrow Capital, the company has nearly tripled its revenue. Its network has grown from 22 to over 60 dialysis centres across nine states and fifty-plus cities, with more than 35,000 patients treated and over 8 lakh dialysis sessions delivered. The company has also grown its workforce from 110 to 300 employees. Faster breakeven at newly opened centres and same-centre growth exceeding 30% contributed to positive corporate EBITDA in FY26.
VitusCare’s expansion is built around a capital-light ‘shop-in-shop’ model that brings specialised dialysis services into existing hospitals. By partnering with hospitals rather than building standalone facilities, the company aims to extend its network while improving operational efficiency. It plans to expand to more than 100 centres by the end of FY27 and is exploring opportunities in select Asian markets.
The fresh capital will support the company’s next phase of growth, including network expansion, technology development and workforce training. VitusCare is also investing heavily in various AI-native business modules to ensure the best possible health care delivery. It also plans to establish a Technician Academy to strengthen the pipeline of skilled dialysis professionals as it scales its operations.
Prabhat Shrivastava, Founder & CEO, VitusCare, said, “This fundraise marks an important milestone in VitusCare’s journey. We are focused on building a sustainable dialysis care model that combines clinical excellence with operational efficiency. The confidence our investors have shown in us reinforces our approach to disciplined growth, improving centre-level performance and strengthening our operational foundation. As we expand our network, we remain focused on maintaining consistent care standards while making quality dialysis services more accessible across underserved markets.”
Vasavi Vittal, Founder & Managing Director of Liberty Ridge Capital, a Singapore-based healthcare growth equity firm, added, “VitusCare’s capital-light model offers a differentiated approach to delivering specialised dialysis care through existing hospital infrastructure. Its growth in network reach, revenue and centre-level performance demonstrates the strength of its operating model. We see an opportunity for VitusCare to build on this foundation and expand its presence across India and select international markets.”
With its capital-light model, technology investments and hospital partnerships, VitusCare further aims to expand access to specialised dialysis care while building a sustainable and scalable network.
